Indication

Moraxella catarrhalis chronic bronchitis

*Moraxella catarrhalis* chronic bronchitis refers to an acute bacterial infection or acute exacerbation of chronic bronchitis caused by the Gram-negative diplococcus *Moraxella catarrhalis*. Read more about Moraxella catarrhalis chronic bronchitis

62 drugs 48 manufacturers

Advertisement

Drugs that treat it

Common Moraxella catarrhalis chronic bronchitis therapies.

Showing 28–36 of 62 drugs

Filter & compare in the drug finder →Opens the drug finder with Moraxella catarrhalis chronic bronchitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Moraxella catarrhalis chronic bronchitis.

*Moraxella catarrhalis* chronic bronchitis refers to an acute bacterial infection or acute exacerbation of chronic bronchitis caused by the Gram-negative diplococcus *Moraxella catarrhalis*.

Primarily affecting the lower respiratory tract in adults with underlying chronic obstructive pulmonary disease or preexisting structural airway damage, the pathogen colonizes the compromised tracheobronchial mucosa and triggers mucosal inflammation.

This infectious insult impairs mucociliary clearance and accelerates inflammatory cell influx, clinically characterized by an acute worsening of baseline respiratory symptoms, including heightened dyspnea, increased cough frequency, and the production of increased volume and purulence of sputum.

Personalize your experience

Follow Moraxella catarrhalis chronic bronchitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it